Help
RSS
API
Feed
Maltego
Contact
Domain > www.diagnosticsworldnews.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2019-12-12
192.225.209.8
(
ClassC
)
2024-07-14
205.174.27.110
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyContent-Type: text/html; charsetUTF-8Location: https://www.diagnosticsworldnews.com/X-Server: 2Date: Sun, 14 Jul 2024 04:26:45 GMTContent-Length: 160 head>title>Document Moved/title>/head>body>h1>Object Moved/h1>This document may be found a HREFhttps://www.diagnosticsworldnews.com/>here/a>/body>
Port 443
HTTP/1.1 200 OKVary: Accept-EncodingCache-Control: no-cacheContent-Type: text/html; charsetutf-8X-Server: 3Date: Sun, 14 Jul 2024 04:26:47 GMTExpires: -1Pragma: no-cacheContent-Length: 68868 !DOCTYPE html> html langen> head> meta http-equivX-UA-Compatible contentIEedge,chrome1 /> meta charsetutf-8 />script typetext/html idsf-tracking-consent-manager> style> /*Consent Form*/ #tracking-consent-dialog { padding: 15px; position: fixed; bottom: 0; right: 5px; width: 337px; border: 3px solid #1e82e0; border-radius: 5px 5px 0px 0px; background: rgba(255, 255, 255, .95); font-size: 16px; z-index: 999; } #tracking-consent-dialog-accept { background-color: #1e82e0; color: #fff; font-size: 16px; font-weight: 500; float: right; } .consent-close { font-weight: bold; float: right; padding: 2px 7px; right: 6px; top: 3px; cursor: pointer; font-size: 11px; position: absolute; background-color: #1e82e0; color: #fff; z-index: 999; border-radius: 50%; } @media (max-width: 767px) { #tracking-consent-dialog { width: 100%; font-size: 14px; } } /style> div idtracking-consent-dialog> div classconsent-close onclickTrackingConsentManager.updateUserConsent(true)>X/div> strong>Cookie Policy/strong> p>CII uses cookies to improve your website & conference experiences, including enhancing website navigation, personalized features & promotions, evaluating our services, and customizing content and ads based on your preferences as you browse or engage with us. By clicking Continue or continuing to use our site, you are agreeing to our and our partners use of cookies. See our a hrefhttps://www.cambridgeinnovationinstitute.com/Privacy-Policy/>Privacy Policy/a> for more information./p> button typebutton onclickTrackingConsentManager.updateUserConsent(true) idtracking-consent-dialog-accept classbtn btn-default>Continue/button> /div>/script>script typetext/javascript src/WebResource.axd?dDzHrpQl5URXarFHAtrmzFrNeeCwCLwHK2gvGZ95fW9WnidZLXrfDlGTuxUr3l463ttkzDVh9D8Bug9pu7NHdr_V4jKJPpR5aBflu4f8Ts5edKoXW2sH8LcSZSfqlYNJ5LpoUn5WBE_fdKcz0yNVMxY3w_4XLcip6ESbZeM3DDdUqeeNFFCEiKQKGKqR186oo0&t637922505220000000>/script> script src/ScriptResource.axd?dokuX3IVIBwfJlfEQK32K3iZZtiInnD21Q3naS01thH9-fzUaksT1ZtMUjWfsR2IfFrdwuSgx30ngwb9MjfyLwf8qicr33ktg3mwcpW2o3dsDH8d3-t4otTq9qT-5mrFfzK1f5nCn185AY5nCZScdoqJ1WOdlA_-4T4B_v3AbufPsc2J5Jr9-kOiHGAB_hap-0&t4e1c7b51 typetext/javascript>/script>script src/ScriptResource.axd?dEydukmxBmDstn7gSYzQESGX1Bc6SUabUViYB9LpdmFW6eZLmGFNo26FA-YqkH5f3QjtPWjAHxth32_ExmLGGY1zv6AdaQenYAqaM29qW1bTxx1r5T--aFytKsL9IQMjnWBhhM3Ox0iMnCMCJK5xrzQardvmrid9DGkma-HwbE57flKsxZSkIFbT-h8oEIp2m0&t4e1c7b51 typetext/javascript>/script>link href/ResourcePackages/Bootstrap/assets/dist/css/main.min.css relstylesheet typetext/css />link href/css/global-pub.css relstylesheet typetext/css />link href/css/editor.css relstylesheet typetext/css /> link href//fonts.googleapis.com/css?familyRoboto:500,400,700 relstylesheet typetext/css> meta nameviewport contentwidthdevice-width, initial-scale1, minimum-scale1, maximum-scale1, user-scalableno /> meta propertyog:title contentDiagnostics World News | Your Resource for Diagnostics Advancements />meta propertyog:description contentYour go-to source for the latest in diagnostics is here. Diagnostics World covers circulating tumor cells, liquid biopsy, point-of-care diagnostics, and more. Discover more today! />meta propertyog:url contenthttps://www.diagnosticsworldnews.com />meta propertyog:type contentwebsite />meta propertyog:site_name contentPubs - Diagnostics World News />script typetext/javascript>!-- Google Tag Manager -->(function(w,d,s,l,i){wlwl||;wl.push({gtm.start:new Date().getTime(),event:gtm.js});var fd.getElementsByTagName(s)0,jd.createElement(s),dll!dataLayer?&l+l:;j.asynctrue;j.srchttps://www.googletagmanager.com/gtm.js?id+i+dl;f.parentNode.insertBefore(j,f);})(window,document,script,dataLayer,GTM-NPQQS7JB);!-- End Google Tag Manager -->/script>script typetext/javascript srchttps://www.googletagservices.com/tag/js/gpt.js>/script>script typetext/javascript> var googletag googletag || {}; googletag.cmd googletag.cmd || ; googletag.cmd.push(function() { googletag.defineSlot(/305762/DiagnosticsWorld, 728, 90, div-gpt-ad-1538580975263-1).addService(googletag.pubads()); googletag.defineSlot(/305762/DiagnosticsWorld, 728, 90, div-gpt-ad-1538580975263-21).addService(googletag.pubads()); googletag.defineSlot(/305762/DiagnosticsWorld, 234, 60, div-gpt-ad-1538580975263-2).addService(googletag.pubads()); googletag.defineSlot(/305762/DiagnosticsWorld, 234, 60, div-gpt-ad-1538580975263-22).addService(googletag.pubads()); googletag.defineSlot(/305762/DiagnosticsWorld, 336, 280, div-gpt-ad-1538580975263-3).addService(googletag.pubads()); googletag.defineSlot(/305762/DiagnosticsWorld, 336, 280, div-gpt-ad-1538580975263-23).addService(googletag.pubads()); googletag.defineSlot(/305762/DiagnosticsWorld, 160, 160, div-gpt-ad-1538580975263-4).addService(googletag.pubads()); googletag.defineSlot(/305762/DiagnosticsWorld, 150, 800, div-gpt-ad-1538580975263-5).addService(googletag.pubads()); googletag.pubads().enableSingleRequest(); googletag.enableServices(); });/script>script typetext/javascript srchttps://platform.twitter.com/widgets.js>/script>link href/css/pubs/dwn.css mediaall relstylesheet typetext/css />style typetext/css mediaall>.navbar-default .navbar-nav>li:first-child, .dropdown-menu>.active>a, .dropdown-menu>.active>a:focus, .navbar-default .navbar-nav>.open>a:hover, .dropdown-menu, .navbar-default .navbar-nav>.open>a, .navbar-default .navbar-nav>li>a:hover, .navbar-default .navbar-nav>.active>a:hover { background-color: #035378; color: #fff;}/style>meta nameGenerator contentSitefinity 14.2.7900.0 DX />link relcanonical hrefhttps://www.diagnosticsworldnews.com />script typeapplication/json idsf-insight-metadata> {contentMetadata:{\Id\:\da6a045e-7001-4628-832a-998078dd8745\,\ContentType\:\Page\,\Title\:\Home\,\CanonicalTitle\:\Home\,\CanonicalUrl\:\https://www.diagnosticsworldnews.com\,\CreatedOn\:\2018-10-10T14:00:02Z\,\ModifiedOn\:\2024-01-03T15:56:17Z\,\SiteName\:\Pubs - Diagnostics World News\,\PageId\:\da6a045e-7001-4628-832a-998078dd8745\},videosMetadata:}/script>script typeapplication/json idsf-insight-settings> {apiServerUrl:https://api.insight.sitefinity.com/,apiKey:62dc77b5-9fbc-74c6-8f79-d05463f0565e,applicationName:CII_DEC,trackingCookieDomain:,keepDecTrackingCookieOnTrackingConsentRejection:false,slidingExpirationForTrackingCookie:false,maxAgeForTrackingCookieInDays:365,trackYouTubeVideos:true,strategy:Persist|False,docsHrefTestExpressions:.*\\/docs\\/.+\\.{1}.+((\\?|\\\u0026)sfvrsn.+){1}$,.+((\\?|\\\u0026)sf_dm_key.+){1}$}/script>script typetext/javascript src/WebResource.axd?dHtQyXelCu6mzSPcVcvK_BrDGcMZ2eaAwTGCTL_5l9xvo0iV9h2YYkvXanQ1uf0LidxbxWd8AzxNrppPmU7C9KnzDV98eKbg88D2zgKyY_GVq-IK4cwpq3ApmVVQHZ20G6_cSyVvbsc3d7cEOVVpoZalFAGFOo2fFcbG9u0riPX3ha1PNvfZCNU2C8dj5lXB2aevtM9BprQUEvuhENe--svD7i9F-8WutvDj5rAfLCkI1&t637922505220000000>/script>script srchttps://cdn.insight.sitefinity.com/sdk/sitefinity-insight-client.min.3.1.7.js asyncasync>/script>link href/Telerik.Web.UI.WebResource.axd?dPMrIT5dOWaVYIcpFWUE4nCGcRFDqtHj8a0dT9N7jtPAWgyp5t5fff0pvXeFargWg3kuRljuyyjKW8grLvrafOr9X0kIEdj24q9AbiZ0prs7qITvLoGQxdqYfpMFPSD250&t638482241021526486&compress0&_TSM_CombinedScripts_%3b%3bTelerik.Sitefinity.Resources%2c+Version%3d14.2.7900.0%2c+Culture%3dneutral%2c+PublicKeyToken%3db28c218413bdf563%3aen%3aec7772cc-ee32-478e-8437-4242283bb12f%3a7a90d6a typetext/css relstylesheet />title> Diagnostics World News | Your Resource for Diagnostics Advancements/title>meta namedescription contentYour go-to source for the latest in diagnostics is here. Diagnostics World covers circulating tumor cells, liquid biopsy, point-of-care diagnostics, and more. Discover more today! />/head> body>form methodpost action./ idaspnetForm>input typehidden namectl04_TSM idctl04_TSM value />input typehidden namectl05_TSSM idctl05_TSSM value />input typehidden name__VIEWSTATE id__VIEWSTATE valuevirxmYcnkgcHOgq1sAvbhzLvHchXzpZhfXX92KR+g3U7u1Bf4kzvAOhfDhrDpY0xp2QuvztoEIP6Hm8qrajqY+F7VahgquHsGLJwzHDofIo />script typetext/javascript>//!CDATAvar __cultureInfo {name:en,numberFormat:{CurrencyDecimalDigits:2,CurrencyDecimalSeparator:.,IsReadOnly:true,CurrencyGroupSizes:3,NumberGroupSizes:3,PercentGroupSizes:3,CurrencyGroupSeparator:,,CurrencySymbol:$,NaNSymbol:NaN,CurrencyNegativePattern:0,NumberNegativePattern:1,PercentPositivePattern:1,PercentNegativePattern:1,NegativeInfinitySymbol:-∞,NegativeSign:-,NumberDecimalDigits:2,NumberDecimalSeparator:.,NumberGroupSeparator:,,CurrencyPositivePattern:0,PositiveInfinitySymbol:∞,PositiveSign:+,PercentDecimalDigits:2,PercentDecimalSeparator:.,PercentGroupSeparator:,,PercentSymbol:%,PerMilleSymbol:‰,NativeDigits:0,1,2,3,4,5,6,7,8,9,DigitSubstitution:1},dateTimeFormat:{AMDesignator:AM,Calendar:{MinSupportedDateTime:\/Date(-62135578800000)\/,MaxSupportedDateTime:\/Date(253402300799999)\/,AlgorithmType:1,CalendarType:1,Eras:1,TwoDigitYearMax:2029,IsReadOnly:true},DateSeparator:/,FirstDayOfWeek:0,CalendarWeekRule:0,FullDateTimePattern:dddd, MMMM d, yyyy h:mm:ss tt,LongDatePattern:dddd, MMMM d, yyyy,LongTimePattern:h:mm:ss tt,MonthDayPattern:MMMM d,PMDesignator:PM,RFC1123Pattern:ddd, dd MMM yyyy HH\u0027:\u0027mm\u0027:\u0027ss \u0027GMT\u0027,ShortDatePattern:M/d/yyyy,ShortTimePattern:h:mm tt,SortableDateTimePattern:yyyy\u0027-\u0027MM\u0027-\u0027dd\u0027T\u0027HH\u0027:\u0027mm\u0027:\u0027ss,TimeSeparator::,UniversalSortableDateTimePattern:yyyy\u0027-\u0027MM\u0027-\u0027dd HH\u0027:\u0027mm\u0027:\u0027ss\u0027Z\u0027,YearMonthPattern:MMMM yyyy,AbbreviatedDayNames:Sun,Mon,Tue,Wed,Thu,Fri,Sat,ShortestDayNames:Su,Mo,Tu,We,Th,Fr,Sa,DayNames:Sunday,Monday,Tuesday,Wednesday,Thursday,Friday,Saturday,AbbreviatedMonthNames:Jan,Feb,Mar,Apr,May,Jun,Jul,Aug,Sep,Oct,Nov,Dec,,MonthNames:January,February,March,April,May,June,July,August,September,October,November,December,,IsReadOnly:true,NativeCalendarName:Gregorian Calendar,AbbreviatedMonthGenitiveNames:Jan,Feb,Mar,Apr,May,Jun,Jul,Aug,Sep,Oct,Nov,Dec,,MonthGenitiveNames:January,February,March,April,May,June,July,August,September,October,November,December,},eras:1,A.D.,null,0};//>/script>script src/Telerik.Web.UI.WebResource.axd?_TSM_HiddenField_ctl04_TSM&compress0&_TSM_CombinedScripts_%3b%3bSystem.Web.Extensions%2c+Version%3d4.0.0.0%2c+Culture%3dneutral%2c+PublicKeyToken%3d31bf3856ad364e35%3aen%3a18f1b484-bbc5-4e2e-8ca4-477603537f34%3aea597d4b typetext/javascript>/script>script src/ScriptResource.axd?dokuX3IVIBwfJlfEQK32K3iZZtiInnD21Q3naS01thH9-fzUaksT1ZtMUjWfsR2IfFrdwuSgx30ngwb9MjfyLwf8qicr33ktg3mwcpW2o3dsDH8d3-t4otTq9qT-5mrFfzK1f5nCn185AY5nCZScdoqJ1WOdlA_-4T4B_v3AbufPsc2J5Jr9-kOiHGAB_hap-0&t4e1c7b51 typetext/javascript>/script>script src/Telerik.Web.UI.WebResource.axd?_TSM_HiddenField_ctl04_TSM&compress0&_TSM_CombinedScripts_%3b%3bTelerik.Sitefinity.Resources%3aen%3aec7772cc-ee32-478e-8437-4242283bb12f%3ab162b7a1 typetext/javascript>/script>script src/Frontend-Assembly/Telerik.Sitefinity.Frontend/Mvc/Scripts/Bootstrap/js/bootstrap.min.js?packageBootstrap&vMTQuMi43OTAwLjA%3d typetext/javascript>/script>script src/js/menu-wsub.js typetext/javascript>/script>input typehidden name__VIEWSTATEGENERATOR id__VIEWSTATEGENERATOR value10CBE956 />input typehidden namectl00$ctl04 idctl04 />script typetext/javascript>//!CDATASys.Application.setServerId(ctl04, ctl00$ctl04);Sys.Application._enableHistoryInScriptManager();//>/script> div classADbody> a hrefhttps://www.nextgenerationdx.com/?utm_sourcediagnosticsworldnews.com&utm_mediumbanner&utm_campaigncb_takeover+ad_20240214 classadlink target_blank> div classADbodyImg> /div> /a> div classmain-content> div idcph1 classcontainer internalHeader> div classrow> !-- Google Tag Manager (noscript) -->noscript>iframe srchttps://www.googletagmanager.com/ns.html?idGTM-NPQQS7JBheight0 width0 styledisplay:none;visibility:hidden>/iframe>/noscript>!-- End Google Tag Manager (noscript) -->div classrow data-sf-elementRow> div idcphHeader_T94A95A75023_Col00 classsf_colsIn col-md-9 data-sf-elementColumn 1 data-placeholder-labelColumn 1>div classsfContentBlock>div iddiv-gpt-ad-1538580975263-1 classpad-left hidden-xs> /div>/div> /div> div idcphHeader_T94A95A75023_Col01 classsf_colsIn col-md-3 data-sf-elementColumn 2 data-placeholder-labelColumn 2>div classsfContentBlock>div iddiv-gpt-ad-1538580975263-2 classad-top-right> /div>/div> /div>/div>div classrow data-sf-elementRow> div idcphHeader_T94A95A75024_Col00 classsf_colsIn col-md-9 data-sf-elementColumn 1 data-placeholder-labelColumn 1>div > div classsf-Long-text >div classLogo>a href/>img src/images/librariesprovider50/template-images/diagnostics-world.jpg?sfvrsn8e5fdbe1_2 altDiagnostics-World titleDiagnostics-World classdxx-logo />/a>/div>/div> /div> /div> div idcphHeader_T94A95A75024_Col01 classsf_colsIn col-md-3 data-sf-elementColumn 2 data-placeholder-labelColumn 2>div > div classsf-Long-text >div classsocial-division>div classAdLeaderBoardSocial>div classAbstract>a hrefhttps://twitter.com/dxworldnews stylecolor:white; target_blank titleTwitter>img border0 src/images/default-source/social/twitter-x-cii-uses_publishing-25x25px.png?sfvrsn72250fc_1 stylepadding-top:5px; titleTwitter altTwitter />/a> a hrefhttps://www.linkedin.com/grp/home?gid8319752 stylecolor:white; target_blank titleLinkedIn>img altLinkedIn border0 src/UploadedImages/social-media-icons/linkedin.png stylepadding-right:5px;padding-top:5px; titleLinkedIn data-sf-ec-immutable />/a> a hrefhttps://www.facebook.com/DiagnosticsWorld stylecolor:white; target_blank titleFacebook>img altFacebook border0 src/UploadedImages/social-media-icons/facebook.png stylepadding-right:5px;padding-top:5px; titleFacebook data-sf-ec-immutable />/a>a hrefhttps://www.instagram.com/diagnostics_world/ target_blank titleinstagram>img altinstagram classsocial-icon src/UploadedImages/social/instagram-gray.png stylemax-width:33px;padding-right:5px;padding-top:5px; titleinstagram data-sf-ec-immutable />/a> a hrefhttps://www.diagnosticsworldnews.com/feeds/diagnostics-daily-news stylecolor:white; target_blank titleRSS>img altRSS border0 src/UploadedImages/social-media-icons/rss.png stylepadding-right:5px;padding-top:5px; titleRSS data-sf-ec-immutable />/a> /div>/div>div classChiLogo>img src/images/librariesprovider50/template-images/a-divisiion-of-chi.png?sfvrsne724d425_2 alta-divisiion-of-chi titlea divisiion of chi data-displaymodeOriginal classimageResize />/div>/div>/div> /div> /div>/div> /div> /div> div idcph1 classcontainer> div classrow> div> div classnavbar navbar-default> div classnavbar-header> button typebutton classnavbar-toggle data-togglecollapse data-target.navbar-collapse> span classicon-bar>/span> span classicon-bar>/span> span classicon-bar>/span> /button> /div> div classcollapse navbar-collapse idbs-example-navbar-collapse-1> ul classnav navbar-nav large-nav rolemenu> li class>a href/subscribe target_self>Subscribe/a>/li> li classdropdown> a href# classdropdown-toggle rolebutton> News /a> ul rolemenu classdropdown-menu> li class> a href/latest-news target_self>Latest News/a> /li> li class> a href/post-a-press-release target_self>Post a Press Release/a> /li> li class> a href/press-releases target_self>View Press Releases/a> /li> li class> a href/story-submission target_self>Submit a Story/a> /li> li class> a href/all-news/reprint-articles target_self>Reprint Articles/a> /li> /ul> /li> li classdropdown> a href# classdropdown-toggle rolebutton> Advertise /a> ul rolemenu classdropdown-menu> li class> a href/media-kit target_self>Media Kit/a> /li> li class> a href/Advertise/Digital-Advertising target_self>Digital Advertising Opportunities/a> /li> li class> a href/advertise/diagnostics-world-media-kit-downloads target_self>Lead Generation/a> /li> li class> a href/advertise/whitepapers target_self>Whitepapers/a> /li> li class> a href/advertise/webinars target_self>Webinars/a> /li> li class> a href/advertise/podcasts target_self>Podcasts/a> /li> li class> a href/advertise/editorial-calender target_blank>Editorial Calender/a> /li> /ul> /li> li classdropdown> a href# classdropdown-toggle rolebutton> Free Downloads /a> ul rolemenu classdropdown-menu> li class> a href/whitepapers target_self>Whitepapers/a> /li> li class> a href/podcasts target_self>Podcasts/a> /li> li class> a href/webinars target_self>Webinars/a> /li> li class> a href/ebooks target_self>Inside Ebooks/a> /li> /ul> /li> li classdropdown> a href# classdropdown-toggle rolebutton> Events /a> ul rolemenu classdropdown-menu> li class> a href/dxx/events/webinars target_self>Webinars/a> /li> li class> a href/events target_self>Industry Events /a> /li> li class> a href/dxx/events/dx-conferences target_self>Dx Conferences/a> /li> li class> a href/dxx/events/tri-conference target_blank>Tri-Conference/a> /li> li class> a href/dxx/events/next-generation-dx target_blank>Next Generation Dx/a> /li> li class> a href/dxx/events/Dx-Innovation-Summit target_blank>Dx Innovation Summit/a> /li> /ul> /li> li classdropdown> a href# classdropdown-toggle rolebutton> About /a> ul rolemenu classdropdown-menu> li class> a href/About/Editorial-Profile target_self>Editorial Profile/a> /li> li class> a href/about/editorial-calender target_blank>Editorial Calender/a> /li> li class> a href/contact target_self>Contact/a> /li> /ul> /li> li class>a href/molecular-med-tri-conference target_blank>Molecular Med Tri-Conference/a>/li> /ul> /div>!-- /.navbar-collapse --> /div>/div> /div> /div> div idcph1 classcontainer internal> div classrow> div classrow data-sf-elementRow> div classcol-md-5 col-sm-6> div idContentplaceholder1_C018_Col00 classsf_colsIn pad-lr data-sf-elementColumn 1 data-placeholder-labelColumn 1>div > div classsf-Long-text >div classcarousel slide home-spacing data-ridecarousel idPub-Carousel>div classcarousel-inner>div classitem active>a hrefhttps://www.diagnosticsworldnews.com/news/2021/05/06/quidel-abbott-begin-rollout-of-at-home-covid-19-antigen-tests>img src/images/librariesprovider50/promos/DXX-Rotation-Home-COVID-407x303.jpg classimageResize altAt Home COVID Tests />/a>/div>div classitem>a hrefhttps://www.diagnosticsworldnews.com/news/2021/07/06/a-glimpse-into-the-future-of-infectious-disease-diagnostics>img src/images/librariesprovider50/promos/DXX-Rotation-Infectious-Diseases-407x303.jpg classimageResize altA Look at the Future of Infectious Disease Diagnostics />/a>/div>div classitem>a hrefhttps://www.diagnosticsworldnews.com/news/2021/07/15/inflammatory-clock-measures-universal-hallmark-of-aging>img src/images/librariesprovider50/promos/DXX-Rotation-Inflammatory-Clock-407x303.jpg classimageResize altInflammatory Clock Measures Aging />/a>/div>div classitem>a hrefhttps://www.diagnosticsworldnews.com/news/2021/06/21/mayo-may-soon-bring-ai-enabled-electrocardiograms-to-the-clinic>img src/images/librariesprovider50/promos/DXX-Rotation-Mayo-ECG.jpg classimageResize altMayo’s AI-Enabled ECGs />/a>/div>div classitem>a hrefhttps://www.diagnosticsworldnews.com/news/2021/06/18/miniaturized-ultrasound-technology-taking-advantage-of-accessibility-not-compromising-quality-of-care>img src/images/librariesprovider50/promos/DXX-Rotation-Portable-Ultrasound-407x303.jpg classimageResize altMaking the Most of Portable Ultrasounds />/a>/div>/div>/div>/div> /div>link href/css/NewsList.css relstylesheet />div classtab-button-div> button classtab-button tab-active left-button iddaily onclickselectNews(event, daily)>DAILY NEWS/button> button classtab-button idpress onclickselectNews(event, press)>PRESS RELEASES/button>/div>div classcustomdxx news-tab> ul classlist-unstyled list-daily distinct-news> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/11/cool-new-tech-tricks-for-tackling-speed-bumps-in-point-of-care-histology titleCool New Tech Tricks for Tackling Speed Bumps in Point-of-Care Histology>Cool New Tech Tricks for Tackling Speed Bumps in Point-of-Care Histology/a>/h3> span classtab-date>Jul 11 | /span> b>Diagnostics World/b> | For more than 150 years now, medical scientists have been hunching over microscopes turning human tissue samples into crisp colored images that help pathologists diagnose diseases. Histology, as the field is known, has made an art of the complex business of creating high-quality microscope slides—and until recently done it in precisely the same way with consistently good results. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/11/cool-new-tech-tricks-for-tackling-speed-bumps-in-point-of-care-histology>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/10/ai-taking-on-the-holy-grail-of-diagnostics-predicting-drug-response titleAI Taking on the Holy Grail of Diagnostics: Predicting Drug Response>AI Taking on the Holy Grail of Diagnostics: Predicting Drug Response/a>/h3> span classtab-date>Jul 10 | /span> b>Diagnostics World/b> | Machine learning models can be superior to radiologists when it comes to processing complex images and putting a predictive label on them, particularly at scale. The problems currently being studied in biomedicine with machine learning, such as identifying the subtype of cancer a patient has, are ones that have been largely ignored for a long time. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/10/ai-taking-on-the-holy-grail-of-diagnostics-predicting-drug-response>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/09/proscia-nucleai-partner-to-link-digital-pathology-ai-predictive-biomarker-platforms titleProscia, Nucleai Partner to Link Digital Pathology, AI-Predictive Biomarker Platforms>Proscia, Nucleai Partner to Link Digital Pathology, AI-Predictive Biomarker Platforms/a>/h3> span classtab-date>Jul 09 | /span> b>Diagnostics World/b> | Proscia and Nucleai are partnering to integrate Nucleai’s predictive biomarker solutions into Proscia’s Concentriq software platform and make them available as part of Proscia’s AI-enabled pathology portfolio to better inform patient care. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/09/proscia-nucleai-partner-to-link-digital-pathology-ai-predictive-biomarker-platforms>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/01/new-ai-system-detects-rare-forms-of-epilepsy-better-than-traditional-models titleNew AI System Detects Rare Forms of Epilepsy Better Than Traditional Models>New AI System Detects Rare Forms of Epilepsy Better Than Traditional Models/a>/h3> span classtab-date>Jul 01 | /span> b>Diagnostics World/b> | Over 3.4 million people in the US and 65 million people worldwide are affected by epilepsy. To ensure that patients are getting the treatment they need, early detection is critical. Researchers at the University of Southern California have developed an AI system called NeuroGNN that can identify epilepsy by analyzing brain interactions with greater accuracy and efficiency. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/01/new-ai-system-detects-rare-forms-of-epilepsy-better-than-traditional-models>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/follow-the-money-foresite-therapeutics-new-fund-invests-in-precision-therapeutics-targeting-autoimmune-inflammatory-diseases-more titleFollow the Money: Foresite Therapeutics’ New Fund Invests in Precision Therapeutics, Targeting Autoimmune, Inflammatory Diseases, More>Follow the Money: Foresite Therapeutics’ New Fund Invests in Precision Therapeutics, Targeting Autoimmune, Inflammatory Diseases, More/a>/h3> span classtab-date>Jun 27 | /span> b>Diagnostics World/b> | Foresite Capital launches fund for three main areas: precision therapeutics, life science infrastructure, and healthcare delivery; Santa Ana Bio employs proteomic, transcriptomic, and genomic approaches to precisely characterize disease-specific subpopulations and identify targets only on disease-causing cell types leaving healthy cells unaffected; more. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/follow-the-money-foresite-therapeutics-new-fund-invests-in-precision-therapeutics-targeting-autoimmune-inflammatory-diseases-more>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/26/pacbio-s-free-hifi-long-read-variant-frequency-database-pathai-releases-new-ai-products-thermo-fisher-unveils-new-pipetting-system-more titlePacBio’s Free HiFi Long-Read Variant Frequency Database, PathAI Releases New AI Products, Thermo Fisher Unveils New Pipetting System, More>PacBio’s Free HiFi Long-Read Variant Frequency Database, PathAI Releases New AI Products, Thermo Fisher Unveils New Pipetting System, More/a>/h3> span classtab-date>Jun 26 | /span> b>Diagnostics World/b> | PacBio, in collaboration with the international Consortium for Long-Read Sequencing (CoLoRS), announced the launch of the first publicly available and free HiFi long-read variant frequency database with global representation; PathAI unveiled two novel AI products, PathExplore Immuno-Oncology Profiling (IOP) and IHC Explore1; , Thermo Fisher Scientific has introduced One Lambda HLA PRO, an automated, modular pipetting system that offers versatility by accommodating different workflows on a single instrument, allowing laboratories to automate multiple human leukocyte antigen (HLA) and antibody testing technologies cost-effectively; more. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/26/pacbio-s-free-hifi-long-read-variant-frequency-database-pathai-releases-new-ai-products-thermo-fisher-unveils-new-pipetting-system-more>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/25/grail-begins-independent-trading-on-nasdaq titleGRAIL Begins Independent Trading on Nasdaq>GRAIL Begins Independent Trading on Nasdaq/a>/h3> span classtab-date>Jun 25 | /span> b>Diagnostics World/b> | GRAIL, previously an Illumina company, began regular trading on Nasdaq today under the ticker symbol GRAL. Illumina continues to trade on Nasdaq under the ticker symbol ILMN. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/25/grail-begins-independent-trading-on-nasdaq>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/21/wearable-device-identifies-biomarker-for-malignant-melanoma titleWearable Device Identifies Biomarker for Malignant Melanoma>Wearable Device Identifies Biomarker for Malignant Melanoma/a>/h3> span classtab-date>Jun 21 | /span> b>Diagnostics World/b> | Researchers at the Karolinska Institute in Stockholm, Sweden, have developed a new device for detecting malignant melanoma. Melanoma affects about one million people every year across the world, and over the past two decades, cases of melanoma have significantly increased due to higher rates of exposure to ultraviolet radiation and climate change. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/21/wearable-device-identifies-biomarker-for-malignant-melanoma>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/18/ai-powered-platform-could-reveal-true-personality-of-tumors titleAI-Powered Platform Could Reveal True Personality of Tumors>AI-Powered Platform Could Reveal True Personality of Tumors/a>/h3> span classtab-date>Jun 18 | /span> b>Diagnostics World/b> | Researchers in Israel who pioneered the discipline of “mechanomics” are now using the concept to fill the chasm between the expanding volume of ‘omics data and its translation into real-world clinical scenarios. Their aim is to help physicians predict the aggressiveness of cancer and a tumor’s potential resistance to treatment and, ultimately, improve patient outcomes. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/18/ai-powered-platform-could-reveal-true-personality-of-tumors>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/12/new-biomarker-offers-hope-of-detecting-alzheimer's-in-asymptomatic-stages titleNew Biomarker Offers Hope of Detecting Alzheimer's in Asymptomatic Stages>New Biomarker Offers Hope of Detecting Alzheimers in Asymptomatic Stages/a>/h3> span classtab-date>Jun 12 | /span> b>Diagnostics World/b> | Until recently, all the available therapeutic options for treating Alzheimer’s disease were designed to reduce symptoms rather than address causes of the disease. But with two beta-amyloid antibodies now approved by the U.S. Food and Drug Administration, and tau-targeting agents in clinical trials, hopes are rising that Alzheimer’s progression can be delayed if not stopped. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/12/new-biomarker-offers-hope-of-detecting-alzheimer's-in-asymptomatic-stages>More/a> /li> /ul> ul classlist-unstyled list-press styledisplay: none> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/11/surfix-diagnostics-the-netherlands-cancer-institute-and-crcbioscreen-join-forces-to-validate-biomarkers-for-colorectal-cancer-screening titleSurfix Diagnostics, the Netherlands Cancer Institute and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening>Surfix Diagnostics, the Netherlands Cancer Institute and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening/a>/h3> span classtab-date>Jul 11 | /span> Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announced a collaboration aimed at enhancing colorectal cancer (CRC) screening methods. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/11/surfix-diagnostics-the-netherlands-cancer-institute-and-crcbioscreen-join-forces-to-validate-biomarkers-for-colorectal-cancer-screening>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/11/synexa-life-sciences-enrols-in-my-green-lab-certification-program titleSynexa Life Sciences Enrols in My Green Lab Certification Program>Synexa Life Sciences Enrols in My Green Lab Certification Program/a>/h3> span classtab-date>Jul 11 | /span> Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/11/synexa-life-sciences-enrols-in-my-green-lab-certification-program>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/10/pascal-piedbois-md-phd-joins-one2treat-as-chief-medical-officer-to-advance-patient-centric-innovation-in-clinical-trial-design-and-market-access titlePascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access>Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access/a>/h3> span classtab-date>Jul 10 | /span> Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access. One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/10/pascal-piedbois-md-phd-joins-one2treat-as-chief-medical-officer-to-advance-patient-centric-innovation-in-clinical-trial-design-and-market-access>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/09/medix-biochemica-announces-that-lonnie-shoff-former-president-of-the-clinical-diagnostics-division-at-thermo-fisher-scientific-has-been-appointed-its-board-of-directors titleMedix Biochemica announces that Lonnie Shoff, former President of the Clinical Diagnostics Division at Thermo Fisher Scientific has been appointed its Board of Directors>Medix Biochemica announces that Lonnie Shoff, former President of the Clinical Diagnostics Division at Thermo Fisher Scientific has been appointed its Board of Directors/a>/h3> span classtab-date>Jul 09 | /span> Medix Biochemica has announced the appointment of Lonnie Shoff to their Board of Directors. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/09/medix-biochemica-announces-that-lonnie-shoff-former-president-of-the-clinical-diagnostics-division-at-thermo-fisher-scientific-has-been-appointed-its-board-of-directors>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/08/cphi-south-east-asia-opens-as-growth-prospects-outlined-for-pharmaceutical-development-in-vietnam-thailand-and-cambodia titleCPHI South East Asia opens as growth prospects outlined for pharmaceutical development in Vietnam, Thailand and Cambodia>CPHI South East Asia opens as growth prospects outlined for pharmaceutical development in Vietnam, Thailand and Cambodia/a>/h3> span classtab-date>Jul 08 | /span> a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/08/cphi-south-east-asia-opens-as-growth-prospects-outlined-for-pharmaceutical-development-in-vietnam-thailand-and-cambodia>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/07/03/indica-labs-expands-availability-of-halo-digital-pathology-solutions-in-asia-pacific-region-including-ce-ivdr-marked-halo-ap-platform titleIndica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform>Indica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform/a>/h3> span classtab-date>Jul 03 | /span> Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/07/03/indica-labs-expands-availability-of-halo-digital-pathology-solutions-in-asia-pacific-region-including-ce-ivdr-marked-halo-ap-platform>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/emmes-partners-with-iliad-biotechnologies-to-conduct-phase-iii-clinical-trials-of-bpze1-the-leading-next-generation-pertussis-vaccine titleEmmes partners with ILiAD Biotechnologies to Conduct Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine>Emmes partners with ILiAD Biotechnologies to Conduct Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine/a>/h3> span classtab-date>Jun 27 | /span> a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/emmes-partners-with-iliad-biotechnologies-to-conduct-phase-iii-clinical-trials-of-bpze1-the-leading-next-generation-pertussis-vaccine>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/avallano-strengthens-leadership-with-new-chief-strategy-officer-to-drive-ai-powered-clinical-research-innovation titleAvallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation>Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation/a>/h3> span classtab-date>Jun 27 | /span> Avallano has ann announced the appointment of Michael A. Ibara, PharmD., as Chief Strategy Officer (CSO). a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/avallano-strengthens-leadership-with-new-chief-strategy-officer-to-drive-ai-powered-clinical-research-innovation>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/proscia-strengthens-leadership-position-in-global-diagnostic-pathology-market titleProscia Strengthens Leadership Position In Global Diagnostic Pathology Market>Proscia Strengthens Leadership Position In Global Diagnostic Pathology Market/a>/h3> span classtab-date>Jun 27 | /span> New KLAS Research report and research study conducted with Quest Diagnostics highlight company’s customer and product momentum a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/proscia-strengthens-leadership-position-in-global-diagnostic-pathology-market>More/a> /li> li classitem > h3>a classtab-title hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/wcg-and-mrct-center-form-task-force-to-tackle-ethical-challenges-in-ai-based-clinical-research titleWCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research>WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research/a>/h3> span classtab-date>Jun 27 | /span> The task force will evaluate AIs use in various aspects of clinical trials, including protocol design, consent considerations, patient privacy and confidentiality, and participant recruitment. It will also evaluate AI when it is being studied as an investigational product for use in medical care. a classmore-link hrefhttps://www.diagnosticsworldnews.com/news/2024/06/27/wcg-and-mrct-center-form-task-force-to-tackle-ethical-challenges-in-ai-based-clinical-research>More/a> /li> /ul> a classview-link href/search-news#?sortPublicationDate%20desc>View more articles/a>/div>script> //Stop buttons from refreshing screen. $(document).ready(function () { //Check for user submit $(#press).on(click, function (event) { event.preventDefault(); }); $(#daily).on(click, function (event) { event.preventDefault(); }); }); //Change news view. function selectNews(evt, sourceName) { // Hide all news. tabcontent document.getElementsByClassName(list-press); for (i 0; i tabcontent.length; i++) { tabcontenti.style.display none; } tabcontent document.getElementsByClassName(list-daily); for (i 0; i tabcontent.length; i++) { tabcontenti.style.display none; } // Make both buttons inactive tabButtons document.getElementsByClassName(tab-button); for (i 0; i tabButtons.length; i++) { tabButtonsi.className tabButtonsi.className.replace( tab-active, ); } // Activate button pressed. evt.currentTarget.className + tab-active; if (sourceName daily) { tabcontent document.getElementsByClassName(list-daily); for (i 0; i tabcontent.length; i++) { tabcontenti.style.display ; } } if (sourceName press) { tabcontent document.getElementsByClassName(list-press); for (i 0; i tabcontent.length; i++) { tabcontenti.style.display ; } } }/script>/div> /div> div classcol-md-4 col-sm-6> div idContentplaceholder1_C018_Col01 classsf_colsIn pad-lr data-sf-elementColumn 2 data-placeholder-labelColumn 2>div classsfContentBlock>br />div iddiv-gpt-ad-1538580975263-3 classtext-center home-spacing>span styledisplay: none;> /span>/div>/div>div > div classsf-Long-text >style>p { display: block; }/style>div classhome-box home-spacing>img src/images/librariesprovider50/template-images/dxx-industry-spotlight.jpg?sfvrsn53ac03a3_2 titleDXX-Industry-spotlight classimageResize data-displaymodeOriginal altDXX-Industry-spotlight />div classhome-box-inner>br />p classtext-center>a hrefhttps://www.sigmaaldrich.com/DE/en/services/ivd-development-manufacturing/custom-diagnostic-antibody-development-and-manufacturing-services?&utm_sourcehealthtech&utm_mediumsponsored%20content&utm_campaignyour%20science%2c%20our%20expertise%2c%20cmo-tid-2023009019 target_blank>img src/images/librariesprovider50/industry-spotlight/merck-vib_m_string.jpg?sfvrsn6b0bc452_1 stylemax-width:200px; classimageResize altmerck />/a>/p>br />p>b>Custom Diagnostic Antibody Development & Manufacturing Services/b>/p>p>Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing./p>p>a hrefhttps://www.sigmaaldrich.com/DE/en/services/ivd-development-manufacturing/custom-diagnostic-antibody-development-and-manufacturing-services?&utm_sourcehealthtech&utm_mediumsponsored%20content&utm_campaignyour%20science%2c%20our%20expertise%2c%20cmo-tid-2023009019 target_blank data-sf-ec-immutable>Learn more/a>/p>/div>/div>/div> /div>div > div classsf-Long-text >div iddiv-gpt-ad-1538580975263-23 classtext-center home-box home-spacing>/div>/div> /div>div > div classsf-Long-text >div classhome-box home-spacing>img src/images/librariesprovider50/template-images/dxx-homepage-featured-videos-325x35.jpg altDXX-Industry-spotlight titleDXX-Industry-spotlight data-displaymodeOriginal classimageResize />br />br />div classhome-box-inner>div classrow pad-top>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal6>img src/images/librariesprovider50/industry-spotlight/21/flow-alliance_logo_payoff_rgb.jpg classimageResize pad-left />/a> /div>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal6> p>strong>Microfluidic Consumable development/strong>/p>/a> /div>/div>/div>div classhome-box-inner>div classrow pad-top>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal7>img src/images/librariesprovider50/industry-spotlight/21/flow-alliance_logo_payoff_rgb.jpg classimageResize pad-left />/a> /div>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal7> p>strong>Diagnostic Consumable development in times of Covid19/strong>/p>/a> /div>/div>/div>div classhome-box-inner>div classrow pad-top>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal5>img src/images/librariesprovider50/industry-spotlight/21/biodesix-logo-pms.png classimageResize pad-left />/a> /div>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal5> p>strong>An Introduction to Biopharma Diagnostic Services at Biodesix/strong>/p>/a> /div>/div>/div>div classhome-box-inner>div classrow pad-top>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal>img src/images/librariesprovider50/default-album/jpg_logo_sg_rgb.jpg classimageResize pad-left />/a> /div>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal> p>strong>Expansion of Diagnostic Consumables/strong>/p>/a> /div>/div>/div>div classhome-box-inner>div classrow pad-top>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal2>img src/images/librariesprovider50/default-album/angle-logo_blue.jpg classimageResize pad-left />/a> /div>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal2> p>strong>Circulating Tumor Cell (CTC) Biopharma Lab Services/strong>/p>/a> /div>/div>/div>div classhome-box-inner>div classrow pad-top>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal3>img src/images/librariesprovider50/default-album/zfbg3o1i-copy.png classimageResize pad-left />/a> /div>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal3> p>strong>SARS-CoV-2 Diagnostics by NGS: Interesting Challenges and Scalable Solutions/strong>/p>/a> /div>/div>/div>div classhome-box-inner>div classrow pad-top>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal4>img src/images/librariesprovider50/industry-spotlight/21/bioivt-logo-250-x-250-(1).png classimageResize pad-left />/a> /div>div classcol-sm-6>a data-togglemodal stylecursor:pointer; data-target#myModal4> p>strong>BioIVT Donor Center Video/strong>/p>/a> /div>/div>/div>/div>!-- Modal -->div classmodal fade centered-modal idmyModal tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close video-close-three data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player styleborder:0px;>div classvideoWrapper>video controls width570 idvideo-three>source srchttps://chi-cloud.s3.amazonaws.com/DXX/Industry-Spotlight/21/Balda-Timelapse.mp4 typevideo/mp4>/source>/video>/div>/div>/div>/div>/div>div classmodal fade centered-modal idmyModal2 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player styleborder:0px;>div classvideoWrapper>video controls width570>source srchttps://chi-cloud.s3.amazonaws.com/DXX/Industry-Spotlight/21/ANGLEpresentation.mp4 typevideo/mp4>/source>/video>/div>/div>/div>/div>/div>div classmodal fade centered-modal idmyModal3 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player styleborder:0px;>div classvideoWrapper>video controls width570 idvideo-one>source srchttps://chi-cloud.s3.amazonaws.com/DXX/Industry-Spotlight/21/ELLLIS-JEREMY-01.26.2021-20m.53s.mp4 typevideo/mp4>/source>/video>/div>/div>/div>/div>/div>div classmodal fade centered-modal idmyModal4 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close video-close-four data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player styleborder:0px;>div classvideoWrapper>video controls width570 idvideo-four>source srchttps://chi-cloud.s3.amazonaws.com/DXX/Industry-Spotlight/21/BioIVT-Donor-Centers-Sept-2020.mp4 typevideo/mp4>/source>/video>/div>/div>/div>/div>/div>div classmodal fade centered-modal idmyModal5 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close video-close-five data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player styleborder:0px;>div classvideoWrapper>video controls width570 idvideo-five>source srchttps://chi-cloud.s3.amazonaws.com/DXX/Industry-Spotlight/21/Biodesix-Biopharma-Services-Video.mp4 typevideo/mp4>/source>/video>/div>/div>/div>/div>/div>div classmodal fade centered-modal idmyModal6 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close video-close-six data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player styleborder:0px;>div classvideoWrapper>video controls width570 idvideo-six>source srchttps://chi-cloud.s3.amazonaws.com/DXX/Industry-Spotlight/21/Flow-Alliance-The-House-of-Microfluidics.mp4 typevideo/mp4>/source>/video>/div>/div>/div>/div>/div>div classmodal fade centered-modal idmyModal7 tabindex-1 roledialog aria-labelledbymyModalLabel>div classmodal-dialog>div classmodal-header>button typebutton classclose video-close video-close-seven data-dismissmodal aria-labelClose>span aria-hiddentrue>×/span>/button>/div>div classmodal-content>div classmodal-body modal-video-player idyt-player styleborder:0px;>div classvideoWrapper>video controls width570 idvideo-seven>source srchttps://chi-cloud.s3.amazonaws.com/DXX/Industry-Spotlight/21/Flow-Alliance-2021-TRICON.mp4 typevideo/mp4>/source>/video>/div>/div>/div>/div>/div>/div> /div>/div> /div> div classcol-sm-12 col-md-3> div idContentplaceholder1_C018_Col02 classsf_colsIn pad-lr data-sf-elementColumn 3 data-placeholder-labelColumn 3>div classsfContentBlock>div classtwitterFeed>a classtwitter-timeline data-height600 hrefhttps://twitter.com/DXWorldNews?ref_srctwsrc%5Etfw>Tweets by DXWorldNews/a>/div>/div>div classsfContentBlock>div iddiv-gpt-ad-1538580975263-5 classtext-center home-spacing> /div>/div>div > div classsf-Long-text >div iddiv-gpt-ad-1538580975263-4 classtext-center home-spacing>/div>/div> /div>/div> /div>/div>div classrow data-sf-elementRow> div classcol-sm-5> div idContentplaceholder1_C017_Col00 classsf_colsIn pad-lr data-sf-elementColumn 1 data-placeholder-labelColumn 1>/div> /div> div classcol-sm-4> div idContentplaceholder1_C017_Col01 classsf_colsIn pad-lr data-sf-elementColumn 2 data-placeholder-labelColumn 2>/div> /div> div classcol-sm-3> div idContentplaceholder1_C017_Col02 classsf_colsIn pad-lr data-sf-elementColumn 3 data-placeholder-labelColumn 3>/div> /div>/div>script typetext/javascript>googletag.cmd.push(function() { googletag.display(div-gpt-ad-1538580975263-1); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1538580975263-21); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1538580975263-2); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1538580975263-22); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1538580975263-3); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1538580975263-23); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1538580975263-4); });googletag.cmd.push(function() { googletag.display(div-gpt-ad-1538580975263-5); });/script>div classrow data-sf-elementRow> div idContentplaceholder1_T94A95A75025_Col00 classsf_colsIn col-md-9 data-sf-elementColumn 1 data-placeholder-labelColumn 1>div > div classsf-Long-text >div iddiv-gpt-ad-1538580975263-21 classhome-spacing hidden-xs pad-left pad-bottom>/div>/div> /div> /div> div idContentplaceholder1_T94A95A75025_Col01 classsf_colsIn col-md-3 data-sf-elementColumn 2 data-placeholder-labelColumn 2>div > div classsf-Long-text >div -ddiv-gpt-ad-1538580975263-22 classhome-spacing>/div>/div> /div> /div>/div> /div> /div> /div> footer> /div>div > div classsf-Long-text >div classfooter>div classcontainer>div classrow>div classcol-sm-3 col-xs-12>div classfooter-small>div classfooter-small-inner>img altCHI | Cambridge HealthTech Institute classCII-footer src/UploadedImages/CHI-logo.png data-sf-ec-immutable />br />p>250 First Avenue, Suite 300br />Needham, MA 02494br />br />P: 781.972.5400br />F: 781.972.5425 br />E: a hrefmailto:chi@healthtech.com?cdtConferenceId404272006.1663694140&cdtRollupId404272006.1663694140 data-sf-ec-immutable>chi@healthtech.com/a> /p>div classrow>div classcol-sm-12 footer-social>a hrefhttps://twitter.com/CHI_Healthtech data-sf-ec-immutable>img src/images/default-source/social/twitter-gray.png?sfvrsnbac909e7_7 alt classfooter-social-icons />/a> a hrefhttps://www.linkedin.com/company/cambridge-healthtech-institute data-sf-ec-immutable>img src/images/default-source/social/linkedin-gray.png?sfvrsned70471e_4 classfooter-social-icons alt />/a> a hrefhttps://www.facebook.com/HealthtechConferences data-sf-ec-immutable>img src/images/default-source/social/facebook-gray.png?sfvrsn35d4a48c_4 classfooter-social-icons alt />/a> /div>/div>/div>/div>/div>div classcol-sm-4 footer-border hidden-xs>div classrow>div classcol-sm-12>p>Life Science Portals/p>/div>div classcol-sm-6>p>a hrefhttp://biologicaltherapeutics.cambridgeinnovationinstitute.com/home>Biological Therapeutic Products/a>/p>p>a hrefhttp://biomarkers.cambridgeinnovationinstitute.com/home>Biomarkers & Diagnostics/a>/p>p>a hrefhttp://biopharmastrategy.cambridgeinnovationinstitute.com/home>Biopharma Strategy/a>/p>p>a hrefhttps://bioprocessing.cambridgeinnovationinstitute.com/home>Bioprocess & Manufacturing/a>/p>p>a hrefhttp://chemistry.cambridgeinnovationinstitute.com/home>Chemistry/a>/p>p>a hrefhttp://clinicaltrials.cambridgeinnovationinstitute.com/home>Clinical Trials &br data-sf-ec-immutable />Translational Medicine/a>/p>p>a hrefhttp://druganddevice.cambridgeinnovationinstitute.com/home>Drug & Device Safety/a>/p>/div>div classcol-sm-6>p>a hrefhttp://drugdevelopment.cambridgeinnovationinstitute.com/home>Drug Discovery & Development/a>/p>p>a hrefhttp://drugtargets.cambridgeinnovationinstitute.com/home>Drug Targets/a>/p>p>a hrefhttp://healthcare.cambridgeinnovationinstitute.com/home>Healthcare/a>/p>p>a hrefhttp://it.cambridgeinnovationinstitute.com/home>IT, AI, ML & Informatics/a>/p>p>a hrefhttp://techtools.cambridgeinnovationinstitute.com/home>Technology & Tools Forbr data-sf-ec-immutable />Life Science/a>/p>p>a hrefhttp://therapeutics.cambridgeinnovationinstitute.com/home>Therapeutic Indications/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/vip-series data-sf-ec-immutable>Venture, Innovation, and Partnering/a>/p>/div>/div>/div>div classcol-sm-3 footer-border hidden-xs>p>CHI Divisions/p>p>a hrefhttps://www.healthtech.com/?cdtConferenceId404272006.1663694140&cdtRollupId404272006.1663694140 data-sf-ec-immutable>Conferences/a>/p>p>a hrefhttps://www.insightpharmareports.com/ data-sf-ec-immutable>Reports & Market Research/a>/p>p>a hrefhttps://www.barnettinternational.com/ data-sf-ec-immutable>Barnett Educational Services/a>/p>p>a hrefhttps://www.healthtech.com/publishing data-sf-ec-immutable>News & Advertising/a>/p>p>a hrefhttps://proservices.healthtech.com/?cdtConferenceId404272006.1663694140&cdtRollupId404272006.1663694140 data-sf-ec-immutable>Professional Services/a>/p>/div>div classcol-sm-2 footer-border hidden-xs>p>Corporate Information/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/ data-sf-ec-immutable>Cambridge Innovationbr />Institute/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/Executive-Team/ data-sf-ec-immutable>Executive Team/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/Testimonials/ data-sf-ec-immutable>Testimonials/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/mailing-list.html data-sf-ec-immutable>Mailing List/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/Careers/ titleCareers data-sf-ec-immutable>Careers/a>/p>hr />p>a hrefhttps://www.cambridgeinnovationinstitute.com/request-information data-sf-ec-immutable>Request Information/a>/p>p>a hrefhttps://www.cambridgeinnovationinstitute.com/Privacy-Policy/ data-sf-ec-immutable>Privacy Policy/a>/p>/div>/div>/div>/div>/div> /div> /footer> script typetext/javascript>//!CDATAwindow.__TsmHiddenField $get(ctl04_TSM);;(function() { function loadHandler() { var hf $get(ctl05_TSSM); if (!hf._RSSM_init) { hf._RSSM_init true; hf.value ; } hf.value + ;Telerik.Sitefinity.Resources, Version14.2.7900.0, Cultureneutral, PublicKeyTokenb28c218413bdf563:en:ec7772cc-ee32-478e-8437-4242283bb12f:7a90d6a; Sys.Application.remove_load(loadHandler); }; Sys.Application.add_load(loadHandler); })();//>/script>/form>script typeapplication/json idPersonalizationTracker> {IsPagePersonalizationTarget:false,IsUrlPersonalizationTarget:true,PageId:da6a045e-7001-4628-832a-998078dd8745}/script>script typetext/javascript src/WebResource.axd?dOiw5o8i74rDb2VpVaCaMSouKRnJ2rn_cgRr8eXgFzWmU6yVv8fmvjGNlDReMboLSikSmK5y_KsDt9j-18b7ZqBNiz0-92AjY43-6qMcq4O__3MjW1Pd6kS68TTYuxCxnF4HnqcusO3ivgfHZzR9usujs8YAzvYku29ledrs3mezPir5ikBP0Pxh4nDmiJEk2WgW0YVPdsdMlu69MVd6jI94nvC3-40pMaRxtm9HTV2I1&t637922505260000000>/script>script typetext/javascript> $(.Tab2).hide(); $(#press-release).click(function(){ $(.Tab2).show(750); $(.Tab1).hide(250); $(.Tab2Btn).addClass(active); $(.Tab1Btn).removeClass(active); }); $(#upcoming).click(function () { $(.Tab1).show(750); $(.Tab2).hide(250); $(.Tab1Btn).addClass(active); $(.Tab2Btn).removeClass(active); });/script>script typetext/javascript> var video document.getElementById(video-one); function stopVideo(){ video.pause(); video.currentTime 0; } var videothree document.getElementById(video-three); function stopVideothree(){ videothree.pause(); videothree.currentTime 0; } var videofour document.getElementById(video-four); function stopVideofour(){ videofour.pause(); videofour.currentTime 0; } var videofive document.getElementById(video-five); function stopVideofive(){ videofive.pause(); videofive.currentTime 0; } var videosix document.getElementById(video-six); function stopVideosix(){ videosix.pause(); videosix.currentTime 0; } var videoseven document.getElementById(video-seven); function stopVideoseven(){ videoseven.pause(); videoseven.currentTime 0; } $(.video-close-six).on(click, function(){ stopVideosix(); }); $(.video-close-seven).on(click, function(){ stopVideoseven(); }); $(.video-close-five).on(click, function(){ stopVideofive(); }); $(.video-close).on(click, function(){ stopVideo(); }); $(.video-close-three).on(click, function(){ stopVideothree(); }); $(.video-close-four).on(click, function(){ stopVideofour(); });/script>/body> /html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]